Kjell Olmarker

Corporate Officer/Principal bei University of Gothenburg

66 Jahre

Health Technology

Consumer Services

Profil

Kjell Olmarker was the founder of PharmaSurgics In Sweden AB, founded in 2005, where he held the title of Director from 2005 to 2009, and Stayble Therapeutics AB, founded in 2015, where he held the title of Director.
Currently, Dr. Olmarker is a Professor at the University of Gothenburg.

Aktive Positionen von Kjell Olmarker

Unternehmen	Position	Beginn
University of Gothenburg	Corporate Officer/Principal	-

Alle aktiven Positionen von Kjell Olmarker

Ehemalige bekannte Positionen von Kjell Olmarker

Unternehmen	Position	Ende
STAYBLE THERAPEUTICS AB	Gründer	-
PharmaSurgics In Sweden AB PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established.	Gründer	-

Sehen Sie sich die Erfahrung von Kjell Olmarker im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kjell Olmarker im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
STAYBLE THERAPEUTICS AB	Health Technology

Private Unternehmen	1
PharmaSurgics In Sweden AB PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established.	Health Technology